VIVUS Inc. (NASDAQ: VVUS) is ripping higher following a positive clinical policy bulletin from Aetna on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE